FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Orphan Status for Gileads Antiviral Remdesivir

FDA approves orphan drug status for Gileads antiviral remdesivir that is being tested as a possible Covid-19 treatment.

Biologics

Fecal Microbiota for Transplantation Safety Alert

FDA says there is a risk of transmitting the SARS-CoV-2 virus through fecal microbiota for transplantation and additional safety precautions are neede...

Medical Devices

Point-of-Care Coronavirus Test Authorized

FDA issues an emergency use authorization for Cepheids point-of-care coronavirus diagnostic, the Cepheid Xpert Xpress SARS-CoV-2 test.

Human Drugs

Genentech Phase 3 Actemra Trial for Coronavirus

FDA green lights a Genentech randomized, double-blind, placebo-controlled Phase 3 clinical trial in collaboration with the Biomedical Advanced Researc...

Human Drugs

Lilly Delays New Studies Under Virus Crisis

Faced with many challenges to the healthcare system during the coronavirus outbreak, Eli Lilly decides to delay most new study starts and pauses enrol...

Federal Register

Guide on Cigarette Packages/Advertisements

Federal Register notice: FDA publishes a final guidance entitled Submission of Plans for Cigarette Packages and Cigarette Advertisements.

Federal Register

Info Request on Combo Product Designations

Federal Register notice: FDA seeks comments on an information collection extension related to its guidance entitled Combination Products: How to Write...

Federal Register

Guide on Compounding Hand Sanitizers

Federal Register notice: FDA makes available a guidance entitled Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products Dur...

Human Drugs

Trump Doubles Down on Off-label Malaria Drug

President Trump continues promoting the malaria drug chloroquine for immediate off-label use to combat the coronavirus.

Human Drugs

Insulin, Other Biologics Transition to New Pathway

FDA says today (3/23) is the first day that insulin and certain other biologic drugs transition to a different regulatory pathway.